
Ep. 209 Ryan Worch: Were There Early Signs Of A Bank Crisis?
Investing With IBD
The Fundamentals of Novo Nordisk
Novo Nordisk is known for its diabetes treatments but now it's getting in the news a lot because of some of those treatments being known for obesity. This is an interesting, you know, I presented this idea to my group months ago, but one of the interesting things that came up in his research was that 74% of adults are classified as either obese year of a week. The amount of people that are obese in this country and around the world is is massive. And they actually have a drug that is working to reduce that. So, another one I'm watching I love it from a fundamental perspective.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.